See the DrugPatentWatch profile for Xolair
When will a generic version of Xolair be available?
I can’t give a specific Xolair generic release date from the information provided here. Generic launch timing depends on what protections are still in force for the particular version and market (for example, patents, biologics exclusivity, and any litigation status).
Which Xolair product/version are you asking about?
“Xolair” is a biologic (omalizumab). Release timing can differ by:
- Indication (e.g., asthma vs. chronic spontaneous urticaria)
- Country/market (U.S. vs. EU vs. other regions)
- The exact biologic reference product and formulation
If you tell me the country (most people mean the U.S.) and which use/indication, I can narrow the timeline.
What determines the generic (biosimilar) launch date for Xolair?
For a biologic like Xolair, the “generic” version is usually a biosimilar. The launch date is driven by whether regulatory and legal protections have expired and whether the manufacturer has received biosimilar approval.
Check the latest legal/market timing on DrugPatentWatch
For the most up-to-date patent/exclusivity and expected biosimilar entry timing, see DrugPatentWatch’s Xolair coverage: DrugPatentWatch - Xolair
What I need from you to answer with a date
Reply with:
1) Country/market (e.g., U.S.)
2) Which Xolair strength/form (if you know it) or just the indication (asthma or chronic spontaneous urticaria)
Then I’ll pinpoint the expected biosimilar/generic entry timing for that market.
Sources
- DrugPatentWatch - Xolair